Polymorphisms in C-Reactive Protein and Glypican-5 Are Associated with Lung Cancer Risk and Gartrokine-1 Influences Cisplatin-Based Chemotherapy Response in a Chinese Han Population

Table 1

Characteristics of patients and controls.

Characteristics	Lung cancer; ( = 309)		Control; ( = 310)
Age (means ± SD, year)	58.2 ± 10.2		50.3 ± 8.1
Sex
Male	235	76.1	197	63.5
Female	74	23.9	113	36.5
Smoking status
Never	94	30.4	188	60.6
Ever	215	69.6	122	39.4
	No.	%
Histology
Adenocarcinoma	110	35.6
Squamous cell carcinoma	116	37.5
Small-cell carcinoma	66	21.3
Large-cell carcinoma	2	0.6
Unspecified lung cancer	15	5.0
Stage
I	67	21.7
II	52	16.8
III	69	22.3
IV	118	38.2
Data uncertain	3	1.0